-Minyanville

Other Tools: Calculators | My Watchlist | My Portfolio

TEVAPHARMIND SP ADR Add to My Watchlist

(NSDQ: TEVA)

Detailed Quote

Last Price	52.72 (11.20.09 5:20 PM EST)
Change (%)	-0.32 (-0.60%)
Volume	4,089,937
Open	52.74
Previous Close	53.04
Day's Range	53.08 - 52.50
Bid / Ask	52.72 / 52.73

Intraday

3 Month

6 Month

1 Year

Average Volume	4,545,490	Shares Outstanding	912.00M
52-Week Range	39.75 - 54.95	Market Cap	48.1B
P/E Ratio	N/A	Earnings Per Share	N/A
Dividend	0.62	Yield	1.17

Symbol	Last	Change (%)
WYE	50.39	+0.00 (+0.00)
SAN	50.37	+0.07 (+0.14%)
0I42	50.12	+0.00 (+0.00)
AZNCF	45.30	+0.00 (+0.00)
LRLCF	108.50	+0.00 (+0.00)

Wed, Nov 18, 2009
	Israel benchmarks steady; Elbit, Formula report Israeli stocks trade little changed, with gains in a couple of the telecoms and scattered interest in technology stocks offset by weakness in Africa-Israel, Teva Pharmaceutical and Israel Chemicals. - MarketWatch
Tue, Nov 17, 2009
	Israel stocks up; Citi calls 0.25%-point rate rise Israeli stocks rise, led by strength in property developer Africa-Israel Investments, Israel Chemicals and Teva Pharmaceutical, while in technology the bulls and bears fought almost to a draw. - MarketWatch
Mon, Nov 16, 2009
	Israel stocks steady; Cellcom off after report TEL AVIV (MarketWatch) -- Israeli stocks were steady to higher on Monday, led by strength in Africa-Israel Investments and Israel Chemicals and offset by some weakness in the banks and videoconferencing specialist Radvision. - MarketWatch
Sun, Nov 15, 2009
	Israel stocks up; Credit Suisse warns on budget Strong showing by Teva Pharmaceutical helps continue November run-up. - MarketWatch
Thu, Nov 12, 2009
	Israel stocks; Makhteshim-Agan sees stronger '10 Israeli stocks were mixed on Thursday, with strength in Israel Chemicals offset by Africa-Israel, the telecoms and Teva Pharmaceutical. - MarketWatch
More Featured Content

Tue, Nov 17, 2009
	BenchmarkJournal.com Receives Analysis on TRMB, TFSL, TEVA, DRIV, UNTD and AMMD NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal. - Marketwire
Tue, Nov 10, 2009
	Teva Receives Final Approval for Generic Prevacid® Delayed-Release Capsules - Business Wire
	Teva Receives Favorable Court Decision Regarding Generic Prevacid® SoluTab - Business Wire
	Market Watch: Sunwin International Neutraceuticals - November 10, 2009 NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts LLC. - Marketwire
	Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE®-Related Patents - Business Wire
More Press Releases

11/03/09		Q3 2009 Earnings Archive for TEVA
09/24/09		Business News Investor Conference Call Archive for TEVA
09/14/09		Special Conference Teva Pharmaceutical at Morgan Stanley Global Healthcare Conference Archive for TEVA
07/28/09		Q2 2009 Earnings Archive for TEVA
05/18/09		Special Conference Deutsche Bank Securities 34th Annual Healthcare Conference Archive for TEVA

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Todd Harrison

Terry Woo

Kevin Depew

Jeff Macke

Andrew Jeffery

Jeffrey Cooper

Dr Janice Dorn

Allan Dodds Frank

John Mauldin

Smita Sadana